№ 3. – с. 70-73. – doi 10.52419/issn2782- 6252.2022.3.70. – edn ppeowv. 7. руководство по проведению доклинических исследований лекарственных средств / научный центр экспертизы средств медицинского приме- нения минздравсоцразвития россии. том часть 1. – москва : гриф и к, 2012. – 944 с. – isbn 978- 5-8125-1466-3. – edn sdewmp. 8. горчаков в.н., гаскина т.к., и горчакова о.в.. “возможности высоких доз стандартизированно- го силимарина при токсических поражениях пе- чени в клинической практике” эксперименталь- ная и клиническая гастроэнтерология, №. 9,- 2012, -с. 71-77. 9. a. ludwiczuk, k. skalicka-woźniak, m.i. georgiev, chapter 11 – terpenoids,editor(s): simo- ne badal, rupika delgoda, pharmacognosy, aca- demic press, 2017, p.233-266

HIGHLIGHTS

SUMMARY

Keyword pr eclinical studies, phar macokinetics, sobr ents, phytobiotics. @@

ACRONYMS

LAY DEFINITIONS

• Terpenoids: A class of compounds composed of repeating 5-carbon units of HEMITERPENES.
• Simo-: Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China
• Pharmacognosy: The science of drugs prepared from natural-sources including preparations from PLANTS, animals, and other organisms as well as MINERALS and other substances included in MATERIA MEDICA. The therapeutic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.